PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.87
ESG score 1.1-1.2x TGTX's 56.79. Guy Spier would verify if superior ESG practices translate to better stakeholder relationships.
50.00
Environmental score 80-90% of TGTX's 56.96. Walter Schloss would scrutinize carbon exposure and transition planning.
61.14
Similar social score to TGTX's 58.69. Bruce Berkowitz would investigate if industry social norms adequately address stakeholder expectations.
68.48
Governance score exceeding 1.2x TGTX's 54.71. Mohnish Pabrai would examine if this governance advantage creates sustainable competitive advantages through better decision-making.